Evaluating effectiveness of CGM in adults with Type 2 Diabetes in a primary care setting

Real-time continuous glucose monitors (rtCGM) are a recent development in diabetes care that has provided individuals with diabetes with access to real-time blood glucose measurements without manual blood drawing and collection. These devices have been found highly effective at improving blood glucose levels in individuals with Type 1 Diabetes and insulin-dependent Type 2 Diabetes, but have not been adequately assessed in the context of individuals with Type 2 Diabetes that do not use meal-time insulin. We plan to evaluate (1) how effective these devices are in this population at improving glycemic control, (2) whether they can prevent or reduce diabetes-related emergency room visits in this population, and (3) qualitatively examine patient-, provider-, and/or practice-level determinants of effective implementation and use of rtCGM.